(VIANEWS) - Merck (MRK), One Liberty Properties (OLP), Ashland (ASH) are the highest payout ratio stocks on this list.
Here's the data we've collected of stocks with a high payout ratio up until now. The payout ratio in itself isn't a guarantee of a future good investment but it's an indicator of whether dividends are being paid and how the company chooses to issue them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. Merck (MRK)
135.45% Payout Ratio
Merck & Co., Inc. provides healthcare solutions worldwide.
Volume
Today's last reported volume for Merck is 9863130, 29.98% below its average volume of 14087100.
As maintained by Morningstar, Inc., the next dividend payment is on Sep 13, 2021, the estimated forward annual dividend rate is 2.6 and the estimated forward annual dividend yield is 3.45%.
Merck's sales growth this year is expected to be negative 2.4% and 8% for next year.
Year-on-year quarterly revenue growth grew by 4.9%, now sitting on 50.38B for the twelve trailing months.
Merck's sales growth is 0.6% for the current quarter and negative 0.8% for the next. The company's growth estimates for the ongoing quarter and the next is 13.1% and 52%.
Volatility
Merck's last day, week, and month's current intraday variation average was 0.76%, 0.72%, and 0.90%, respectively.
Merck's highest amplitude of average volatility was 1.12% (day), 1.74% (last week), and 2.34% (last month), respectively.
Merck's Stock Yearly Top and Bottom Value
Merck's stock is valued at $77.22 at 07:23 EST, way under its 52-week high of $91.40 and way higher than its 52-week low of $68.44.
Merck's Moving Average
Merck's value is below its 50-day moving average of $80.76 and higher than its 200-day moving average of $76.92.Previous days news about Merck (MRK)
- According to Bloomberg Quint on Monday, 14 February, "Divi's has a contract with Merck for global Molnupiravir (Covid-19) API supplies, which is likely to have contributed to performance in this quarter."
- Unlearn and Merck collaborate on medical twins trials. According to VentureBeat on Wednesday, 16 February, "Unlearn and Merck KGaA have announced a partnership to accelerate drug trials using medical digital twins of patients. "
2. One Liberty Properties (OLP)
105.26% Payout Ratio
One Liberty is a self-administered and self-managed real estate investment trust incorporated in Maryland in 1982.
Volume
Today's last reported volume for One Liberty Properties is 37636, 40.64% below its average volume of 63411.
According to Morningstar, Inc., the next dividend payment is on Dec 16, 2021, the estimated forward annual dividend rate is 1.8 and the estimated forward annual dividend yield is 5.97%.
One Liberty Properties's sales growth this year is anticipated to be negative 0.2% and 2.3% for next year.
Year-on-year quarterly revenue growth declined by 3.7%, now sitting on 79.98M for the twelve trailing months.
One Liberty Properties's sales growth is 8.1% for the current quarter and 8.6% for the next. The company's growth estimates for the present quarter is 70%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.05%.
Volatility
One Liberty Properties's last day, week, and month's current intraday variation average was 0.99%, 0.80%, and 1.15%, respectively.
One Liberty Properties's highest amplitude of average volatility was 3.59% (day), 2.81% (last week), and 3.29% (last month), respectively.
One Liberty Properties's Stock Yearly Top and Bottom Value
One Liberty Properties's stock is valued at $30.00 at 07:23 EST, way below its 52-week high of $36.60 and way above its 52-week low of $20.57.
One Liberty Properties's Moving Average
One Liberty Properties's value is under its 50-day moving average of $33.17 and under its 200-day moving average of $30.59.3. Ashland (ASH)
49.37% Payout Ratio
Ashland Global Holdings Inc. provides additives and specialty ingredients worldwide.
Volume
Today's last reported volume for Ashland is 398469, 5.16% below its average volume of 420151.
As claimed by Morningstar, Inc., the next dividend payment is on Feb 27, 2022, the estimated forward annual dividend rate is 1.2 and the estimated forward annual dividend yield is 1.25%.
Ashland's sales growth this year is anticipated to be 9.1% and 5.9% for next year.
Year-on-year quarterly revenue growth declined by 7.2%, now sitting on 2.16B for the twelve trailing months.
The company's growth estimates for the current quarter and the next is 3.8% and 8.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.51%.
Volatility
Ashland's last day, week, and month's current intraday variation average was 2.01%, 1.09%, and 1.00%, respectively.
Ashland's highest amplitude of average volatility was 1.73% (day), 2.04% (last week), and 2.30% (last month), respectively.
Ashland's Stock Yearly Top and Bottom Value
Ashland's stock is valued at $95.24 at 07:23 EST, way below its 52-week high of $110.74 and way above its 52-week low of $81.93.
Ashland's Moving Average
Ashland's worth is under its 50-day moving average of $102.53 and higher than its 200-day moving average of $93.92.4. Nu Skin Enterprises (NUS)
34.2% Payout Ratio
Nu Skin Enterprises, Inc. develops and distributes personal care and wellness products worldwide.
Volume
Today's last reported volume for Nu Skin Enterprises is 162303, 75.26% below its average volume of 656251.
As maintained by Morningstar, Inc., the next dividend payment is on Nov 23, 2021, the estimated forward annual dividend rate is 1.52 and the estimated forward annual dividend yield is 2.86%.
Nu Skin Enterprises's sales growth this year is expected to be 3.8% and 0.6% for next year.
Year-on-year quarterly revenue growth declined by 8.8%, now sitting on 2.77B for the twelve trailing months.
Nu Skin Enterprises's sales growth is negative 12.3% for the present quarter and negative 1.7% for the next. The company's growth estimates for the ongoing quarter and the next is negative 32.9% and negative -6.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 26.07%.
Volatility
Nu Skin Enterprises's last day, week, and month's current intraday variation average was 0.14%, 2.61%, and 1.90%, respectively.
Nu Skin Enterprises's highest amplitude of average volatility was 2.60% (day), 3.69% (last week), and 3.43% (last month), respectively.
Nu Skin Enterprises's Stock Yearly Top and Bottom Value
Nu Skin Enterprises's stock is valued at $51.51 at 07:23 EST, way below its 52-week high of $63.85 and way higher than its 52-week low of $39.40.